EClinicalMedicine Bennett, C L, Hoque, S, Olivieri, N, Taylor, M A, Aboulafia, D, Lubaczewski, C, Bennett, A C, Vemula, J, Schooley, B, Witherspoon, B J, Godwin, A C, Ray, P S, Yarnold, P R, Ausdenmoore, H C, Fishman, M, Herring, G, Ventrone, A, Aldaco, J, Hrushesky, W J, Restaino, J, Thomsen, H S, Marx, R, Migliorati, C, Ruggiero, S, Nabhan, C, Carson, K R, McKoy, J M, Yang, Y T, Schoen, M W, Knopf, K, Martin, L, Sartor, O, Rosen, S & Smith, W K 2021, ' Consequences to patients, clinicians, and manufacturers when very serious adverse drug reactions are identified (1997–2019) : A qualitative analysis from the Southern Network on Adverse Reactions (SONAR) ', EClinicalMedicine, vol. 31, 100693 . https://doi.org/10.1016/j.eclinm.2020.100693 EClinicalMedicine, Vol 31, Iss, Pp 100693-(2021)
Bennett, C L, Schooley, B, Taylor, M A, Witherspoon, B J, Godwin, A, Vemula, J, Ausdenmoore, H C, Sartor, O, Tony Yang, Y, Armitage, J O, Hrushesky, W J, Restaino, J, Thomsen, H S, Yarnold, P R, Young, T, Knopf, K B & Chen, B 2019, ' Caveat medicus : Clinician experiences in publishing reports of serious oncology-associated adverse drug reactions ', PLoS ONE, vol. 14, no. 7, e0219521 . https://doi.org/10.1371/journal.pone.0219521 PLoS ONE PLoS ONE, Vol 14, Iss 7, p e0219521 (2019)